Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

CAFs, cancer-associated fibroblasts; CAR-T, chimeric antigen receptor-T; CRC, colorectal cancer; ECM, extracellular matrix; MDSCs, myeloid-derived suppressor cells; TAMs, tumor-associated macrophages; ...

Sanofi’s Sarclisa has been approved by the European Union as the first anti-CD38 therapy in combination with VRd to treat adult patients with n ...

Connie Campbell was 11 years old when she discovered she had a type of brain tumor called medulloblastoma [a rare primary central nervous system tumor] just days after going on rollercoaster prompted ...

About 9,560 new cases will be diagnosed with CML (5,610 in men and 3,950 in women) About 1,290 people will die of CML (740 men and 550 women) About 15% of all new cases of leukemia are chronic myeloid ...

Many people become confused over the definitions of a primary vs secondary or second cancer. Primary cancer is defined as the original site (organ or tissue) where cancer began. In contrast, a second ...

Tom Shaw is no longer able to walk and had to learn how to speak again after having a brain tumor removed. He’s sharing his story to encourage others to get checked early on and not to ignore symptoms ...

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. The Food and Drug Administration (FDA) approval of ...

The purpose of this study was to compare the efficacy and safety of subcutaneous, sublingual, oral specific immunotherapy in patients who suffer from allergic conditions to pollen from trees, grasses ...